Antidiabetic activity of perylenequinonoid-rich extract from Shiraia bambusicola in KK-Ay mice with spontaneous type 2 diabetes mellitus

Journal of Ethnopharmacology

Volumn 191, Issue , 2016, Pages 71-81

  Huang, Mi ^a   Zhao, Ping ^a   Xiong, Mingrui ^a   Zhou, Qi ^a   Zheng, Sijian ^a   Ma, Xinhua ^a   Xu, Chan ^a   Yang, Jing ^a   Yang, Xinzhou ^a,b   Zhang, Tong Cun ^b  

^a SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

^b TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PLANT EXTRACT; SHIRAIA BAMBUSICOLA EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ACETIC ACID DERIVATIVE; ACETIC ACID ETHYL ESTER; ACETYL COENZYME A CARBOXYLASE; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; LIPID; PERYLENE; SLC2A4 PROTEIN, RAT; SOLVENT;

ACUTE TOXICITY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL PROTOCOL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY ASSAY; DIET RESTRICTION; DRUG MECHANISM; ENZYME PHOSPHORYLATION; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN TOLERANCE TEST; LIPID METABOLISM; MALE; MEDICINAL PLANT; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SHIRAIA BAMBUSICOLA; SKELETAL MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; ASCOMYCETES; BLOOD; CELL LINE; CHEMISTRY; DIABETES MELLITUS, TYPE 2; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; ELECTROSPRAY MASS SPECTROMETRY; INSULIN RESISTANCE; ISOLATION AND PURIFICATION; LD50; LIQUID CHROMATOGRAPHY; METABOLISM; MICROBIOLOGY; PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; SASA; SIGNAL TRANSDUCTION; SKELETAL MYOBLAST; TIME FACTOR;

ACETATES; ACETYL-COA CARBOXYLASE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ASCOMYCOTA; BIOMARKERS; BLOOD GLUCOSE; BLOTTING, WESTERN; CELL LINE; CHROMATOGRAPHY, LIQUID; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE TRANSPORTER TYPE 4; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LETHAL DOSE 50; LIPIDS; MALE; MYOBLASTS, SKELETAL; PERYLENE; PHOSPHORYLATION; PROTEIN TRANSPORT; RATS; SASA; SIGNAL TRANSDUCTION; SOLVENTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TIME FACTORS;

EID: 84975217605     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2016.06.018     Document Type: Article

References (45)

1. M. Arrese Nonalcoholic fatty liver disease: liver disease: an overlooked complication of diabetes mellitus Nat. Rev. Endocrinol. 6 2010 660 661
2. N.J. Bryant, R. Govers, and D.E. James Regulated transport of the glucose transporter GLUT4 Nat. Rev. Mol. Cell Biol. 3 2002 267 277
3. D.A. Buchner, A. Charrier, E. Srinivasan, L. Wang, M.T. Paulsen, M. Ljungman, D. Bridges, and A.R. Saltiel Zinc finger protein 407 (ZFP407) regulates insulin-stimulated glucose uptake and glucose transporter 4 (Glut4) mRNA J. Biol. Chem. 290 10 2015 6376 6386
4. L.H. Cazarolli, D.F. Pereira, V.D. Kappel, P. Folador, S. Figueiredo Mdos, M.G. Pizzolatti, and F.R. Silva Insulin signaling: a potential signaling pathway for the stimulatory effect of kaempferitrin on glucose uptake in skeletal muscle Eur. J. Pharmacol. 712 1-3 2013 1 7
5. M.D. Fullerton, G.R. Steinberg, and J.D. Schertzer Immunometabolism of AMPK in insulin resistance and atherosclerosis Mol. Cell Endocrinol. 366 2012 224 234
6. S.C. Gad, and C.P. Chengelis Acute toxicology testing 1997 Academic Press, Suit 1900, San Diego Califormia
7. W.T. Garvey, L. Maianu, and T.P. Huecksteadt Pre-translation suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity J. Clin. Invest. 87 1991 1072 1081
8. R. Gover Molecular mechanisms of GLUT4 regulation in adipocytes Diabetes Metab. 40 2014 400 410
9. H.D. Grahame AMP-activated protein kinase: a key regulator of energy balance with many roles in human disease J. Intern. Med. 276 2014 543 559
10. C.E. Hagberg, A. Mehlem, A. Falkevall, L. Muhl, B.C. Fam, H. Ortsäter, P. Scotney, D. Nyqvist, E. Samén, L. Lu, S. Stone-Elander, J. Proietto, S. Andrikopoulos, A. Sjöholm, A. Nash, and U. Eriksson Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes Nature 490 2012 426 430
11. K. He, X.G. Li, X. Chen, X.L. Ye, J. Huang, Y.N. Jin, P.P. Li, Y.F. Deng, Q. Jin, Q. Shi, and H.J. Shu Evaluation of antidiabetic potential of selected traditional Chinese medicines in STZ-induced diabetic mice J. Ethnopharmacol. 137 2011 1135 1142
12. S. Huang, and M.P. Czech The GLUT4 glucose transporter Cell Metab. 5 2007 237 252
13. H. King, R.E. Aubert, and W.H. Herman Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections Diabetes Care 21 1998 1414 1431
14. C.T. Lee, J.R. Ussher, A. Mohammad, A. Lam, and G.D. Lopaschuk 5′-AMP activated protein kinase increases glucose uptake independent of GLUT4 translocation in cardiac myocytes Can. J. Physiol. Pharmacol. 92 2014 307 314
15. Y.S. Lee, W.S. Kim, K.H. Kim, M.J. Yoon, H.J. Cho, Y. Shen, J.M. Ye, C.H. Lee, W.K. Oh, C.T. Kim, C. Hohnen-Behrens, A. Gosby, E.W. Kraegen, D.E. James, and J.B. Kim Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant state Diabetes 55 2006 2256 2264
16. N.M. Leguisamo, A.M. Lehnen, U.F. Machado, M.M. Okamoto, M.M. Markoski, G.H. Pinto, and B.D. Schaan GLUT4 content decreases along with insulin resistance and high levels of inflammatory markers in rats with metabolic syndrome Cardiovasc. Diabetol. 11 2012 100
17. J.M. Lenhard, and W.K. Gottschalk Preclinical developments in type 2 diabetes Adv. Drug Deliv. Rev. 54 2002 1199 1212
18. Z. Lian, Y. Li, J. Gao, K. Qu, J. Li, L. Hao, S. Wu, and H. Zhu A novel AMPK activator, WS070117, improves lipid metabolism discords in hamsters and HepG2 cells Lipids Health Dis. 10 2011 67
19. X.H. Liang, Y.J. Cai, X.R. Liao, and Z.Y. Wei The progress of research on medicinal fungus Shiraia bambusicola J. Food Sci. Biotech. 27 2008 1673 1689
20. G.R. Li, Y. Wang, X. Luo, X.M. Mao, and L.L. Li The pharmacodynamics study of hypoglycemic Ziyabiti tablet J. Xinjiang Med. Univ. 33 2010 1171 1174
21. W.L. Li, H.C. Zheng, J. Bukuru, and N. De Kimpe Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus J. Ethnopharmacol. 92 2004 1 21
22. F. Liu, Q. Dallas-Yang, G. Castriota, P. Fischer, F. Santini, M. Ferrer, J. Li, T.E. Akiyama, J.P. Berger, B.B. Zhang, and G. Jiang Development of a novel GLUT4 translocation assay for identifying potential novel therapeutic targets for insulin sensitization Biochem. J. 418 2009 413 420
23. S.Z. Liu, Y.X. Deng, B. Chen, X.J. Zhang, Q.Z. Shi, and X.M. Qiu Antihyperglycemic effect of the traditional Chinese scutellaria-coptis herb couple and its main components in streptozotocin-induced diabetic rats J. Ethnopharmacol. 145 2013 490 498
24. N.M. Maruthur, M.O. Gribble, W.L. Bennett, S. Bolen, L.M. Wilson, P. Balakrishnan, A. Sahu, E. Bass, W.H. Kao, and J.M. Clark The pharmacogenetics of type 2 diabetes: a systematic review Diabetes Care 37 2014 876 886
25. D.E. Moller New drug targets for type 2 diabetes and the metabolic syndrome Nature 414 2001 821 827
26. G. Naresh, N. Jaiswal, P. Sukanya, A.K. Srivastava, A.K. Tamrakar, and T. Narender Glucose uptake stimulatory effect of 4-hydroxypipecolic acid by increased GLUT 4 translocation in skeletal muscle cells Bioorg. Med. Chem. Lett. 22 2012 5648 5651
27. S. Nishiumi, and H. Ashida Rapid preparation of a plasma membrane fraction from adipocytes and muscle cells: application to detection of translocated glucose transporter 4 on the plasma membrane Biosci. Biotechnol. Biochem. 71 2007 2343 2346
28. P. Pushparaj, C.H. Tan, and B.K. Tan Effects of Averrhoa bilimbi leaf extract on blood glucose and lipids in streptozotocin-diabetic rats J. Ethnopharmacol. 72 2000 69 76
29. R. Rana, E.C. Blowers, and A. Natarajan Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases J. Med. Chem. 58 2014 2 29
30. A.R. Saltiel, and C.R. Kahn Insulin signalling and the regulation of glucose and lipid metabolism Nature 414 2001 799 806
31. T. Sanli, G.R. Steinberg, G. Singh, and T. Tsakiridis AMP-activated protein kinase (AMPK) beyond metabolism: a novel genomic stress sensor participating in the DNA damage response pathway Cancer Biol. Ther. 15 2013 156 169
32. D.B. Savage, K.F. Petersen, and G.I. Shulman Disordered lipid metabolism and the pathogenesis of insulin resistance Physiol. Rev. 87 2007 507 520
33. D.F. Su, and X.Y. Wang Metformin vs insulin in the management of gestational diabetes: a systematic review and meta-analysis Diabetes Res. Clin. Pract. 104 2014 353 357
34. M.J. Tan, J.M. Ye, N. Turner, C. Hohnen-Behrens, C.Q. Ke, C.P. Tang, T. Chen, H.C. Weiss, E.R. Gesing, A. Rowland, D.E. James, and Y. Ye Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway Chem. Biol. 15 2008 263 273
35. G.K. Thampy, M.J. Haas, and A.D. Mooradian Troglitazone stimulates acetyl-CoA carboxylase activity through a post-translational mechanism Life Sci. 68 2000 699 708
36. N. Turner, J.Y. Li, A. Gosby, S.W. To, Z. Cheng, H. Miyoshi, M.M. Taketo, G.J. Cooney, E.W. Kraegen, D.E. James, L.H. Hu, J. Li, and J.M. Ye Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex IA mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action Diabetes 57 2008 1414 1418
37. L.V. Viana, J.L. Gross, and M.J. Azevedo Dietary intervention in patients with gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials on maternal and newborn outcomes Diabetes Care 37 2014 3345 3355
38. C. Wang, J. Yang, P. Zhao, Q. Zhou, Z.N. Mei, G.Z. Yang, X.Z. Yang, and Y.J. Feng Chemical constituents from Eucalyptus citriodora Hook leaves and their glucose transporter 4 translocation activities Bioorg. Med. Chem. Lett. 24 2014 3096 3099
39. Y.L. Wang, Z.Q. Xiao, S. Liu, L.S. Wan, Y.D. Yue, Y.T. Zhang, Z.X. Liu, and J.C. Chen Antidiabetic effects of Swertia macrosperma extracts in diabetic rats J. Ethnopharmacol. 150 2013 536 544
40. J. Yang, P. Zhao, D. Wan, Q. Zhou, C. Wang, G.W. Shu, Z.N. Mei, and X.Z. Yang Antidiabetic effect of methanolic extract from Berberis julianae Schneid. via activation of AMP-activated protein kinase in type 2 diabetic mice Evid. Based Complement. Altern. Med. 2014 2014 106206 10.1155/2014/106206
41. X.Z. Yang, J. Yang, C. Xu, M. Huang, Q. Zhou, J.N. Lv, X.H. Ma, C.Q. Ke, Y. Ye, G.W. Shu, and P. Zhao Antidiabetic effects of flavonoids from Sophora flavescens EtOAc extract in type 2 diabetic KK-ay mice J. Ethnopharmacol. 171 2015 161 170
42. S. Yonemitsu, H. Nishimura, M. Shintani, R. Inoue, Y. Yamamoto, H. Masuzaki, and K. Nakao Troglitazone induces GLUT4 translocation in L6 myotubes Diabetes 50 2001 1093 1101
43. C.Y. Zhang, L.E. Parton, C.P. Ye, S. Krauss, R. Shen, C.T. Lin, J.J. Porco, and B.B. Lowell Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity-and high glucose-induced β cell dysfunction in isolated pancreatic islets Cell. Metab. 3 2006 417 427
44. H. Zhang, H. Matsuda, A. Kumahara, S. Nakamura, and M. Yoshikawa New type of anti-diabetic compounds from the processed leaves of Hydrangea macrophylla var. thunbergii (Hydrangeae Dulcis Folium) Bioorg. Med. Chem. Lett. 17 2007 4972 4976
45. P. Zimmet, K.G.M.M. Alberti, and J. Shaw Global and societal implications of the diabetes epidemic Nature 414 2001 782 787